These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30379086)

  • 1. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R.
    Jackson C; De Carvalho M; Genge A; Heiman-Patterson T; Shefner JM; Wei J; Wolff AA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):506-512. PubMed ID: 30379086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
    Andrews JA; Meng L; Kulke SF; Rudnicki SA; Wolff AA; Bozik ME; Malik FI; Shefner JM
    JAMA Neurol; 2018 Jan; 75(1):58-64. PubMed ID: 29181534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):86-91. PubMed ID: 27915482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Respiratory domain of revised amyotrophic lateral sclerosis. Functional Rating Scale].
    Lima SE; Pessolano FA; Monteiro SG; De Vito EL
    Medicina (B Aires); 2009; 69(5):547-53. PubMed ID: 19897441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis?
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):120-3. PubMed ID: 25205208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial.
    Shefner JM; Jacobsen B; Kupfer S; Malik FI; Meng L; Wei J; Wolff AA; Rudnicki SA
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):162-169. PubMed ID: 37641579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of respiratory functions by spirometry and phrenic nerve studies in patients of amyotrophic lateral sclerosis.
    Singh D; Verma R; Garg RK; Singh MK; Shukla R; Verma SK
    J Neurol Sci; 2011 Jul; 306(1-2):76-81. PubMed ID: 21496826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis.
    Shefner JM; Wolff AA; Meng L; Bian A; Lee J; Barragan D; Andrews JA;
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):426-435. PubMed ID: 26982815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosis.
    Jahandideh S; Taylor AA; Beaulieu D; Keymer M; Meng L; Bian A; Atassi N; Andrews J; Ennist DL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):294-302. PubMed ID: 29260584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
    Cedarbaum JM; Stambler N; Malta E; Fuller C; Hilt D; Thurmond B; Nakanishi A
    J Neurol Sci; 1999 Oct; 169(1-2):13-21. PubMed ID: 10540002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
    WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed dynamometry is more sensitive than vital capacity or ALS rating scale.
    Andres PL; Allred MP; Stephens HE; Proffitt Bunnell M; Siener C; Macklin EA; Haines T; English RA; Fetterman KA; Kasarskis EJ; Florence J; Simmons Z; Cudkowicz ME
    Muscle Nerve; 2017 Oct; 56(4):710-715. PubMed ID: 28120413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.
    WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 19 STUDY GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):55-63. PubMed ID: 28872920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.